2012: International Sub-specialty Meeting: “New Frontiers In Progeria Research”
International Sub-specialty Meeting – “New Frontiers In Progeria Research”
In January 2012, PRF convened a specialized meeting of high level researchers not currently funded by PRF, and either new to the field of Progeria or not yet working in it. Designed by the PRF Medical Research Committee, the goal of this 2-day, highly interactive meeting was to stimulate and broaden research by involving researchers qualified to fill essential “holes” in the current field. We thank the participants for accepting this opportunity to brainstorm how to address important unanswered questions towards saving children with Progeria.
Left to Right: Brian Schreiber, MD, V.P. Medical Affairs, Sigma-Tau Pharmaceuticals, Maryland
Ronald Kahn, MD, Senior Investigator, Harvard and Joslin Diabetes Center, Boston, MA
Andrei Gudkov, PhD, DSci, Director & Chief Scientific Officer, Cleveland BioLab, Buffalo, New York
Valerie M. Weaver, PhD, Prof. Surgery, Dir. Therapeutics, University of California San Francisco, CA
*Tom Glover, PhD, Professor of Human Genetics, University of Michigan
Adrian R. Krainer, PhD, Chair, Cancer and Molec. Biology, Cold Spring Harbor Lab., New York
*Judy Campisi, PhD, Senior Scientist, Lawrence Berkeley National Laboratory, CA
*Ted Brown, MD, PhD, Director, NY State Institute for Basic Research in Developmental Disabilities
*Leslie Gordon, MD, PhD, Medical Director, PRF, Brown U. Harvard U.
*Bryan Toole, PhD, Prof. Cell Biology and Anatomy, Medical University of South Carolina
*Christine Harling-Berg, PhD, Brown U.
Walter Cabri, DCh, R&D Chemistry, Director of Analytical Development, Sigma Tau, Rome, Italy
Vicente Andres Garcia, PhD, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
*Frank Rothman, PhD, Professor Emeritus, Brown U.
*Tom Misteli, PhD, Senior Investigator, National Cancer Institute
Jamal Tazi, PhD, Professor, Centre Nationale de Recherche Scientifique, Montpellier, France
*Monica Kleinman, MD, Critical Care and Anesthesia, Boston Children’s Hospital, Harvard
(not shown – Jeffrey Chamberlain, PhD, PI Dept of Neurology, University of Washington, Seattle, WA and Dir., Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center.
*PRF Medical Research Committee member